344 results on '"Haddow, James E."'
Search Results
2. Modeling risk for severe adverse outcomes using angiogenic factor measurements in women with suspected preterm preeclampsia
3. Cost Effectiveness Of Antenatal Screening For Cystic Fibrosis [with Reply]
4. Implications of High Free Thyroxine (FT4) Concentrations in Euthyroid Pregnancies: The FaSTER Trial
5. Screen positive rates among six family history screening protocols for breast/ovarian cancer in four cohorts of women
6. Sequential first- and second-trimester TSH, free thyroxine, and thyroid antibody measurements in women with known hypothyroidism: a FaSTER trial study
7. First- and second-trimester thyroid hormone reference data in pregnant women: a FaSTER (First- and Second-Trimester Evaluation of Risk for aneuploidy) Research Consortium study
8. The impact of maternal plasma DNA fetal fraction on next generation sequencing tests for common fetal aneuploidies
9. Maternal Thyroxine and Fetal Brain Development: The Latest Chapter, a Look Back, and Considerations for the Future
10. Circulating angiogenic proteins in trisomy 13
11. DNA sequencing of maternal plasma to identify Down syndrome and other trisomies in multiple gestations
12. Mid-Gestational Maternal Free Thyroxine Concentration and Offspring Neurocognitive Development at Age Two Years
13. The relationship between PTH and 25-hydroxy vitamin D early in pregnancy
14. Further insights into implications of undetectable or very low unconjugated estriol in maternal serum during the second trimester
15. Prevalence of steroid sulfatase deficiency in California according to race and ethnicity
16. Maternal urine and serum steroid measurements to identify steroid sulfatase deficiency (STSD) in second trimester pregnancies
17. Patient and Health Professional Acceptance of Integrated Serum Screening for Down Syndrome
18. Variability in Thyroid-Stimulating Hormone Suppression by Human Chronic Gonadotropin during Early Pregnancy
19. Dehydrosteroid measurements in maternal urine or serum for the prenatal diagnosis of Smith–Lemli–Opitz syndrome (SLOS)
20. Hyperglycosylated-hCG (h-hCG) and Down syndrome screening in the first and second trimesters of pregnancy
21. Major fetal abnormalities associated with positive screening tests for Smith-Lemli-Opitz syndrome (SLOS)
22. Urine Iodine Measurements, Creatinine Adjustment, and Thyroid Deficiency in an Adult United States Population
23. Identifying Smith-Lemli-Opitz syndrome in conjunction with prenatal screening for Down syndrome
24. Repeated measurement of pregnancy-associated plasma protein-A (PAPP-A) in Down syndrome screening: A validation study
25. Screening for thyroid disorders during pregnancy: Results of a survey in Maine
26. Integrated serum screening for Down syndrome in primary obstetric practice
27. Screening for thyroid disorder during pregnancy: Results of a survey in Maine
28. Is first trimester measurement of sex hormone binding globulin a possible screening test for gestational diabetes mellitus?
29. Prenatal screening for cystic fibrosis
30. Prevalence of GAD Autoantibodies in Women With Gestational Diabetes: A retrospective analysis
31. Maternal Thyroid Deficiency during Pregnancy and Subsequent Neuropsychological Development of the Child
32. Age-related prevalence of Down syndrome
33. Prenatal Screening for Open Neural-Tube Defects in Maine
34. Antenatal screening for Down's syndrome
35. Screening for Cystic Fibrosis
36. Screening of Maternal Serum for Fetal Down's Syndrome in the First Trimester
37. Current Down syndrome risk estimates are reliable
38. Maternal serum screening for Down syndrome in the United States: A 1995 survey
39. Undetectable maternal serum unconjugated estriol levels in the second trimester: Risk of perinatal complications associated with placental sulfatase deficiency
40. Prenatal screening for cystic fibrosis: An updated perspective
41. Down's syndrome screening with nuchal translucency
42. Nicked free β-subunit and Down syndrome screening
43. Intervening to Reduce Environmental Tobacco Smoke Exposure in Infants
44. Down's syndrome screening
45. Computer software programs and Down's syndrome risk calculations
46. Prenatal Screening for Down's Syndrome in Maine, 1980 to 1993
47. Cost effectiveness of antenatal screening of cystic fibrosis: Couple screening would be easier for many centres
48. Are DADs (discriminant aneuploidy detection) as good as MOMs (multiples of the median)?
49. Associations between adverse perinatal outcome and serially obtained second- and third-trimester maternal serum alpha-fetoprotein measurements
50. Decision analysis and screening for Down's syndrome: Testing should be in all women
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.